BeOne Medicines Ltd.

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONC and other ETFs, options, and stocks.

About ONC

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations.

CEO

John V. Oyler

CEOJohn V. Oyler

Employees

12,000

Employees12,000

Headquarters

Basel, Basel-Landschaft (Basle Country)

HeadquartersBasel, Basel-Landschaft (Basle Country)

Founded

2010

Founded2010

Employees

12,000

Employees12,000

ONC Key Statistics

Market cap

33.75B

Market cap33.75B

Price-Earnings ratio

60.28

Price-Earnings ratio60.28

Dividend yield

—

Dividend yield—

Average volume

344.66K

Average volume344.66K

High today

$273.81

High today$273.81

Low today

$265.29

Low today$265.29

Open price

$270.00

Open price$270.00

Volume

203.75K

Volume203.75K

52 Week high

$385.22

52 Week high$385.22

52 Week low

$239.25

52 Week low$239.25

ONC News

TipRanks 4d

BeOne Medicines Executives Quietly Cash In on a Wave of Insider Stock Sales

New insider activity at BeOne Medicines ( (ONC) ) has taken place on June 18, 2026. Claim 55% Off TipRanks Unlock powerful investing tools and data-driven insig...

TipRanks 4d

BeOne Medicines Investors Track New Data from BeiGene’s Chronic Urticaria Trial

BeOne Medicines (ONC) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for m...

TipRanks 4d

BeOne Medicines’ BGB-45035 Trial Completion: What Early Skin Data Could Mean for ONC Investors

BeOne Medicines (ONC) announced an update on their ongoing clinical study. Claim 55% Off TipRanks Unlock powerful investing tools and data-driven insights with...

Analyst ratings

96%

of 24 ratings

Buy

95.8%

Hold

4.2%

Sell

More ONC News

TipRanks 5d

BeOne Medicines Advances BGB-58067 With Key Drug-Interaction Study in Healthy Volunteers

BeOne Medicines (ONC) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for m...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.